Russell Flannery, Forbes Staff

Author's posts

Accelerate Cures Through International Collaboration In Clinical Trials: Cancer Moonshot Pathways

President Joe Biden in February launched a “Cancer Moonshot” initiative that aims to reduce the death rate from cancer by 50% in the next 25 years. Experts from Memorial Sloan Kettering suggest how to proceed

Incentivize The Fight Against Cancer That Affects Kids: Cancer Moonshot Pathways

Leukemia is the most frequently diagnosed cancer among children, and can have harsh long-term impacts among survivors after treatments.

“Why Is Cancer Less Important To Cure Faster Than Covid? — Cancer Moonshot Pathways

“We need to take some lessons from Covid,” says Dr. Elizabeth Jaffee of John Hopkins University

Meet The Scientist Coordinating Joe Biden’s New Cancer Moonshot

Danielle Carnival is open to new ideas and international collaboration

Break Through Barriers To Drive Progress: Cancer Moonshot Pathways

President Joe Biden in February launched a “Cancer Moonshot” initiative that aims to reduce the death rate from cancer by 50% in the next 25 years. How can it be achieved?

Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech

Genuine Biotech rec’d China approval on Monday for use of HIV drug in Covid-19 treatment

“Wealth” Products Hurt Globally Acquisitive Pharmaron Beijing’s 1st Half Profit

Hong Kong-trade shares have lost nearly 36% in past year

Taiwan’s Momentum As Tech Hub “Waning,” AmCham Taiwan Says

Taipei needs to “continue removing outstanding barriers to trade and investment,” group says

China’s Fosun Pharma Invests $158 Mln For 60% Stake In Singapore Cancer Treatment Centers

Purchase to help expansion in Southeast Asia

Pharmaron Beijing Says Profit Rose Amid U.S., UK Expansion

Chinese-American billionaire Lou Boliang guides the way